Vascudyne
PrivateLast Round
Grant
Jun 1, 2025
Total Funding Raised
$14M
Company Overview
Vascudyne is a biotechnology company that develops a bioengineered tissue platform designed to create implantable blood vessels and heart valves for cardiovascular care.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vascudyne Comparables
Compare Vascudyne with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xeltis | 87% | |
| Anova Biomedical | 81% | |
| VeriGraft | 81% | |
Vascudyne Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2025 | ||||
| Series A | Dec 2, 2021 |
Key People
Founding team and executive leadership
Vascudyne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Congressionally Directed Medical Research Programs | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 83% MoM.
- Jun 1, 2025
$4M grant received from Congressionally Directed Medical Research Programs.
Vascudyne Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vascudyne's valuation, stock price, and market status.